Skip to content

Arbutus Biopharma Corporation ABUS Change in Deferred Revenue

Change in Deferred Revenue at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$163.36M
ALN
Alnylam PharmaceuticalsALNY
-$1.63M+94.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$8.03M-160%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$1.08M-75.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$6.36M+14.9%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$0+100%

Other financials

Income statement

See full
Revenue$179.1M+10,055%
Operating income$168.9M+757%
Net income$169.7M+792%
EPS (diluted)$0.87+769%

Balance sheet

See full
Cash & equivalents$23.7M-36.1%
Total debt$631.0K-46.9%
Total equity$260.2M+229%
Total assets$277.2M+137%

Cash flow

See full
Operating cash flow-$8.1M+39.4%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$871.14M+32.6%
Enterprise value$848.07M+36.6%
P/E5.4×
P/S4.6×-98.0×

Profitability

See full
Operating margin81.7%+42.1pp
Net margin84%+43.4pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity94.7%+65.1pp
Debt / equity0.0×
Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arbutus Biopharma Corporation's change in deferred revenue?
Arbutus Biopharma Corporation (ABUS) reported change in deferred revenue of $0 in Q1 2026.
How has Arbutus Biopharma Corporation's change in deferred revenue changed year-over-year?
Arbutus Biopharma Corporation's change in deferred revenue increased by 100.0% year-over-year, from -$812K to $0.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.